Young Song

Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial

Brad H. Rovin, Jonathan Barratt, Hiddo J.L. Heerspink et al. · The Lancet · 2023 · 224 citations · Full text

Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial

Hiddo J.L. Heerspink, Jai Radhakrishnan, Charles E. Alpers et al. · The Lancet · 2023 · 203 citations · Full text

Glomerulonephritis, Active-controlled Clinical Trial, Renal Function +9

Clopidogrel Responsiveness Regardless of the Discontinuation Date Predicts Increased Blood Loss and Transfusion Requirement After Off-Pump Coronary Artery Bypass Graft Surgery

Young Lan Kwak, Jongchan Kim, Yong Seon Choi et al. · Journal of the American College of Cardiology · 2010 · 141 citations · Full text

Thrombosis, Cardiovascular Disease, Coronary Artery Disease +10

Pharmacodynamic analysis of intravenous bolus remimazolam for loss of consciousness in patients undergoing general anaesthesia: a randomised, prospective, double-blind study

Dongwoo Chae, Hyun‐Chang Kim, Young Song et al. · British Journal of Anaesthesia · 2022 · 125 citations · Full text

Intravenous Bolus Remimazolam, Anesthesia Practice, Pharmacodynamic Analysis +8

Comparison of remimazolam-based and propofol-based total intravenous anesthesia on postoperative quality of recovery: A randomized non-inferiority trial

Jeong Yeon Choi, Hye Sun Lee, Ji Young Kim et al. · Journal of Clinical Anesthesia · 2022 · 122 citations · Full text